ResearcherEast China Normal UniversityNo recent work listed

Yunqi Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2841-1253; OpenAlex author ID A5101668888. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper

Papers 2

Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer. Co-author DOI 10.4155/fmc-2022-0168 ↗
Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targetin… Co-author DOI 10.1021/acs.jmedchem.9b00059 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yihua Chen · 2 shared papers, 2019–2022 · strength 0.24
- Paper Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic ca… DOI 10.4155/fmc-2022-0168 ↗
- Paper Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancr… DOI 10.1021/acs.jmedchem.9b00059 ↗
Zhengfang Yi · 2 shared papers, 2019–2022 · strength 0.24
- Paper Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic ca… DOI 10.4155/fmc-2022-0168 ↗
- Paper Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancr… DOI 10.1021/acs.jmedchem.9b00059 ↗
Peng He · 1 shared paper, 2022 · strength 0.16
- Paper Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic ca… DOI 10.4155/fmc-2022-0168 ↗
Haijun Gu · 1 shared paper, 2022 · strength 0.16
- Paper Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic ca… DOI 10.4155/fmc-2022-0168 ↗
Mingyao Liu · 1 shared paper, 2019 · strength 0.08
- Paper Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancr… DOI 10.1021/acs.jmedchem.9b00059 ↗
Xin Wang · 1 shared paper, 2019 · strength 0.08
- Paper Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancr… DOI 10.1021/acs.jmedchem.9b00059 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.